OLD National Bancorp IN cut its position in McKesson Co. (NYSE:MCK) by 11.8% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 9,169 shares of the company’s stock after selling 1,229 shares during the period. OLD National Bancorp IN’s holdings in McKesson were worth $1,073,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Proficio Capital Partners LLC raised its holdings in shares of McKesson by 161.2% during the fourth quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock valued at $25,000 after purchasing an additional 137 shares during the last quarter. Bedel Financial Consulting Inc. boosted its stake in shares of McKesson by 165.2% during the fourth quarter. Bedel Financial Consulting Inc. now owns 236 shares of the company’s stock valued at $26,000 after acquiring an additional 147 shares during the last quarter. Smart Portfolios LLC acquired a new stake in shares of McKesson during the first quarter valued at $35,000. Investors Research Corp acquired a new stake in shares of McKesson during the first quarter valued at $36,000. Finally, Dubuque Bank & Trust Co. boosted its stake in shares of McKesson by 106.7% during the first quarter. Dubuque Bank & Trust Co. now owns 341 shares of the company’s stock valued at $40,000 after acquiring an additional 176 shares during the last quarter. 86.23% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE:MCK opened at $126.45 on Tuesday. The stock has a market cap of $25.82 billion, a P/E ratio of 9.32, a P/E/G ratio of 1.36 and a beta of 1.23. The company has a current ratio of 1.02, a quick ratio of 0.57 and a debt-to-equity ratio of 0.88. McKesson Co. has a one year low of $106.11 and a one year high of $151.86.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be issued a dividend of $0.39 per share. The ex-dividend date is Friday, May 31st. This represents a $1.56 annualized dividend and a yield of 1.23%. McKesson’s dividend payout ratio is presently 11.50%.
A number of equities analysts have recently commented on MCK shares. Zacks Investment Research upgraded McKesson from a “hold” rating to a “buy” rating and set a $144.00 price objective on the stock in a report on Monday, February 4th. Barclays reiterated a “hold” rating and set a $130.00 target price on shares of McKesson in a report on Friday, February 1st. Deutsche Bank upgraded McKesson from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a report on Friday, January 25th. UBS Group initiated coverage on McKesson in a report on Thursday, January 17th. They set a “neutral” rating and a $134.00 target price on the stock. Finally, Wolfe Research initiated coverage on McKesson in a report on Tuesday, April 2nd. They set an “outperform” rating on the stock. Two analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $134.90.
COPYRIGHT VIOLATION WARNING: This article was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/05/14/mckesson-co-mck-holdings-cut-by-old-national-bancorp-in.html.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Read More: Trading Penny Stocks
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.